Abstract

Abstract Background and Aims Analysis of the clinical features of headache in patients on the program dialysis. Method The study included 40 males and 40 females with CKD on program dialysis for more than 12 months in 2022, each session lasting 4 hours. The exclusion criteria were patients receiving drugs that can cause headache and with any type of primary headache not associated with the HD procedure, diabetes mellitus, and others. Patients with DH were further compared with patients without DH in terms of BP and blood values such as urea, creatinine, Na+, K+. Results 45% (n = 36) reported DH, which was common in women 60%. Differences between pre- and post-dialysis urea values in patients with DH were statistically significant (p<0.05). Patients with DH showed significantly higher mean SBP and DBP values before dialysis compared with patients without DH (systolic, P<0.001; diastolic, P<0.01). 80% of patients (n = 64) reported the quality of their headaches as being throbbing, whereas (20%, n = 6) had headaches with dull character. Headache intensity was moderate in 73% (n = 58) and severe in 27% (n = 22). The headache duration was reported to last less than 4 hours in 63% (n = 50) and 4 to 36 hours in 37% (n = 30), Table 2. Conclusion We determined that DH is a common type of headache among HD patients, female predominance, begins after several hours of therapy, with progressive intensity and throbbing character, which is not associated with a coexisting primary headache, but may be related to differences in urea levels and BP before and after treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call